PHASE 1 CLINICAL TRIAL USING AUTOLOGOUS, MUC1-ACTIVATED T CELLS EXPANDED FROM PERIPHERAL BLOOD IN PATIENTS WITH RELAPSED AND RESISTANT OVARIAN CANCER

Mayo Clinic Arizona, Scottsdale AZ

Investigators